32 research outputs found
Optimal Delivery Strategy for Stem Cell Therapy in Patients with Ischemic Heart Disease
Stem cell therapy is a new strategy for patients with ischemic heart disease. However, no consensus exists on the most optimal delivery strategy, but an important factor that determines the success of stem cell therapy is the choice of cell delivery route to the heart. Delivery strategy affects the fate of cells and subsequently influences outcome of procedure. Our review summarizes current approaches for administration of stem cells to the heart. Three most used approaches are intracoronary, intramyocardial, and epicardial injection. They have been widely used for delivery of different types of cells. There are several advantages of these stem cell administration approaches, but stem cell retention and stem cell survival rates are quite low using these methods, which might limit their therapeutic effects. Alternative attempts to improve current stem cell therapy methods are reviewed along with emerging new stem cell delivery approaches. The present chapter displays the current status on stem cell delivery techniques, their efficacy, and clinical success in different trials
Medullary Thyroid Carcinoma: Recent Updates on the Diagnosis and Management
Medullary thyroid carcinoma is a hormone-producing malignant tumor that synthesizes calcitonin. MTC can be sporadic or familial. It has a malignant behavior. Our chapter has 3 parts: 1.Updates on the diagnosis of MTC -in this part we review the clinical findings in MTC: isolated thyroid nodule, palpable cervical lymph nodes and systemic manifestations. Fine needle aspiration, serum calcitonin, computed tomography (CT) and fludeoxyglucose - positron emission tomograpyh (FDG-PET) are summarized. Biomarkers with prognostic value are be described in detail: plasma calcitonin, carcino-embryonic antigen, germ-line RET mutation and matrix metalloproteinase. 2. Updates on the management and treatment of MTC -we discuss the surgical treatment, radiation therapy, systemic therapy with angiogenesis inhibitors and transcatheter arterial embolization to prevent extension of the tumor. Based on the characteristics of MTC a new approach using gene therapy has been developed to obtain complete remission of the carcinoma. 3. We describe a typical case of MTC from the oncology department, with cervical lymph nodes and a thyroid nodule. Immunohistochemistry staining showed calcitonin in the tumor cells. Thyroid ultrasound with fine needle aspiration biopsy confirmed the MTC. CT images of the cervical lymph nodes and thyroid nodule as well as microscopy images are presented. Chemotherapy with Dacarbazine was initiated with favorable outcome
Iron-Deficiency Anemia
Iron is an important element in living systems as it participates in a series of metabolic processes including DNA synthesis and oxygen and electron transport. Iron deficiency is the most common cause of anemia globally being an important healthcare problem. If left untreated, iron-deficiency anemia (IDA) can cause significant morbidity and often is the result of a more serious underlying condition. Correcting iron deficiency and replenishing iron reserves are important objectives of a well-conducted treatment, but diagnosis should prompt further investigation to establish the cause for potential reversal. Age, tolerance, preferred route of administration, and severity of anemia are some of the patient’s characteristics which require an individualized approach
Cardiac Anatomy for the Electrophysiologist with Emphasis on the Left Atrium and Pulmonary Veins
This chapter aims to provide basic anatomical knowledge for the interventional electrophysiologists to understand catheter placement and ablation targets. We begin with the location of the heart inside the mediastinum, position of cardiac chambers, pericardial space and neighboring structures of the heart. We continue with the right atrium and important structures inside it: sinus node, cavotricuspid isthmus, Koch’s triangle and interatrial septum with fossa ovalis. A special part of this chapter is dedicated to the left atrium and pulmonary veins with the venoatrial junction, important structures for catheter ablation of atrial fibrillation. We finish our description with both ventricles with outflow tracts and the coronary venous system
Lessons learned from SARS-CoV and MERS-CoV : FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
SARS-CoV-2 is a newly emerging infectious disease, which originated from Wuhan in the Hubei province of China in late December 2019 [1]. Since then, it has rapidly spread all over the world, and at the time of writing this letter, WHO statistics show more than 1,696,588 cases and 105,952 deaths confirmed across the world [2]. Although there is no specific therapy for SARS-CoV-2 infection [3], combination therapy with antiviral and anti-inflammatory drugs accompanied by supportive treatment have been used for SARS-CoV-2 patients [4]. The combination of well-known HIV protease inhibitors, such as ritonavir with lopinavir, has also been a common approach to treat SARS-CoV-2. Insufficient outcome in severe cases is, however, one of the main challenges associated with the current antiviral-based therapy for SARS-CoV-2 [5]. In view of the long period required for novel drug discovery and the desperate need for a prompt response to this pandemic infection, one must resort to repurposing FDA-approved drugs. In this direction, our experience with other close members of coronaviruses such as SARS and MERS has taught us that repurposing the current drugs is a reasonable strategy.
Abelson tyrosine-protein kinase 2 (Abl2), the imatinib target, was required for efficient SARS-CoV and MERS-CoV replication in vitro [6]. Coleman et al. have shown that the imatinib target Abl2 is indispensable for efficient replication of SARS-CoV and MERS-CoV in vitro
Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization
Lung cancer is currently the first cause of cancer-related death. The major lung cancer subtype is non-small cell lung cancers (NSCLC), which accounts for approximatively 85% of cases. The major carcinogenic associated with lung cancer is tobacco smoke, which produces long-lasting and progressive damage to the respiratory tract. The progressive and diffuse alterations that occur in the respiratory tract of patients with cancer and premalignant lesions have been described as field cancerization. At the level of tumor cells, adjacent tumor microenvironment (TME) and cancerized field are taking place dynamic interactions through direct cell-to-cell communication or through extracellular vesicles. These molecular messages exchanged between tumor and nontumor cells are represented by proteins, noncoding RNAs (ncRNAs) and microRNAs (miRNAs). In this paper, we analyze the miRNA roles in the macrophage polarization at the level of TME and cancerized field in NSCLC. Identifying molecular players that can influence the phenotypic states at the level of malignant cells, tumor microenvironment and cancerized field can provide us new insights into tumor regulatory mechanisms that can be further modulated to restore the immunogenic capacity of the TME. This approach could revert alterations in the cancerized field and could enhance currently available therapy approaches
Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization
Lung cancer is currently the first cause of cancer-related death. The major lung cancer subtype is non-small cell lung cancers (NSCLC), which accounts for approximatively 85% of cases. The major carcinogenic associated with lung cancer is tobacco smoke, which produces long-lasting and progressive damage to the respiratory tract. The progressive and diffuse alterations that occur in the respiratory tract of patients with cancer and premalignant lesions have been described as field cancerization. At the level of tumor cells, adjacent tumor microenvironment (TME) and cancerized field are taking place dynamic interactions through direct cell-to-cell communication or through extracellular vesicles. These molecular messages exchanged between tumor and nontumor cells are represented by proteins, noncoding RNAs (ncRNAs) and microRNAs (miRNAs). In this paper, we analyze the miRNA roles in the macrophage polarization at the level of TME and cancerized field in NSCLC. Identifying molecular players that can influence the phenotypic states at the level of malignant cells, tumor microenvironment and cancerized field can provide us new insights into tumor regulatory mechanisms that can be further modulated to restore the immunogenic capacity of the TME. This approach could revert alterations in the cancerized field and could enhance currently available therapy approaches
Author Correction: Assessment of the frequency of coughing and sneezing triggered by nasopharyngeal swabbing in the pandemic setting
Brain-Computer Virtual Reality Interface System for Brainwave Analysis in Medical Recovery
International audienc